Navigation Links
Treatment for New, Deadly Coronavirus Shows Promise
Date:4/19/2013

THURSDAY, April 18 (HealthDay News) -- A treatment for a new coronavirus that has caused 11 deaths, mostly in the Middle East, shows promise in early tests, U.S. government researchers report.

The investigators discovered that a combination of two antiviral drugs -- ribavirin and interferon-alpha 2b -- can stop the so-called nCoV coronavirus from multiplying in laboratory-grown cells. While the results suggest that this drug combination could be used to treat patients infected with nCoV, more research is needed to confirm these early findings.

Both drugs are approved in the United States for treating people with hepatitis C.

The nCoV coronavirus was first identified in Saudi Arabia in September 2012. As of April 16, 2013, there had been 17 reported cases, including 11 deaths. Most cases have occurred in the Middle East.

While the number of cases is small, there has been person-to-person transmission of the nCoV coronavirus in situations where people -- mainly family members -- have had close contact with infected people, the researchers noted in a news release from the U.S. National Institute of Allergy and Infectious Diseases (NIAID).

That, along with the high death rate, led the NIAID researchers to look for treatments. In laboratory tests using cells from two monkey species, the research team found that either ribavirin or interferon-alpha 2b alone could stop nCoV from replicating in the cells.

However, the drug concentrations needed to do this were higher than what is recommended for people. The researchers then combined the two drugs, and found that they were effective at a dose that can be used in people, according to the study in the April 18 issue of the journal Scientific Reports.

More information

The U.S. Centers for Disease Control and Prevention has more about the nCoV coronavirus.


'/>"/>
Copyright©2012 ScoutNews,LLC.
All rights reserved  

Page: 1 2

Related medicine news :

1. Liver disease: Understanding it will enable the provision of better treatment
2. The Daytop New Jersey Day School Program is Now Accepting Applications for Adolescents in Need of Substance Abuse Treatment and Education on an Outpatient Basis
3. Is your migraine preventive treatment balanced between drugs benefits and harms?
4. Novel Drug Treatment Quickly Reverses Alzheimer’s Disease Resulting in a Significant Reduction in Assisted Living Expenses
5. Dr. Ken Reed and Reed Migraine Centers Hosts New York Migraine Treatment Seminar
6. Differences in staging and treatment likely to be behind UKs low bowel cancer survival
7. NYC Osteopathic Specialist Now Offers Fast-Acting Treatment for Neck and Back Pain
8. Freezing Treatment May Help Destroy Lung Tumors: Study
9. Key bone marrow protein identified as potential new leukemia treatment target
10. Midtown Dentistry Combats Mouth Wounds During Radiation Treatment with New Medications
11. Pine Nut Oil Is A Treatment for Gastritis
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Treatment for New, Deadly Coronavirus Shows Promise
(Date:7/31/2015)... ... 2015 , ... “Engage: Don’t Just Age” will be the ... symposiums, hosted by Massachusetts-based Harmony Healthcare International at Foxwoods Resort Casino in ... executives, administrators, directors of nursing, rehabilitation managers and other management and corporate personnel ...
(Date:7/31/2015)... Seattle, WA (PRWEB) , ... July 31, 2015 , ... ... rapidly transforming the way we treat aging diseases. , BioViva announces it has ... to treat patients with Alzheimer’s Disease (AD) and find a cure. MaxLife will grant ...
(Date:7/31/2015)... ... , ... The alarm was ringing. Hugh Chatfield, survivor of a severe 1987 brain injury, almost ... his equipment was set up to depict the newly poured concrete. With a clear view ... photo speaks for itself. Chatfield is also a highly praised safety and drug education speaker/comedian. ...
(Date:7/31/2015)... ... ... Awarded to only the Top 10 hair transplant practices in the United ... recipients of the Center of Clinical Excellence for ARTAS Robotic Hair Transplantation . ... science of hair transplant. , Parsa Mohebi Hair Restoration is known worldwide for their ...
(Date:7/31/2015)... (PRWEB) , ... July 31, 2015 , ... ... selected as a contributor for LeadingAge’s Center for Aging Services Technologies (CAST) Medication ... to help long-term and post-acute care providers understand the benefits of using ...
Breaking Medicine News(10 mins):Health News:Harmony Healthcare International Announces Speaker Line-up for “HARMONY 2015” 2Health News:Harmony Healthcare International Announces Speaker Line-up for “HARMONY 2015” 3Health News:BioViva USA, Inc.’s Alzheimer’s Disease Gene Therapy Human Trial 2Health News:BioViva USA, Inc.’s Alzheimer’s Disease Gene Therapy Human Trial 3Health News:Prestigious Medical Award Given To Parsa Mohebi Hair Restoration for Excellence in Hair Transplantation 2Health News:LeadingAge Selects Eldermark Case Study to Highlight Medication Error Reduction Results 2Health News:LeadingAge Selects Eldermark Case Study to Highlight Medication Error Reduction Results 3
... the Wall Street Journal and Congressional,Quarterly to Head Kaiser ... to Readers and News,Organizations, MENLO PARK, Calif., Oct. ... News (KHN), an independent,news service, to report on the ... and policy debates surrounding it., The goal of ...
... Morria Biopharmaceuticals Plc, a,biopharmaceutical company focused ... today the preliminary results from its,recently completed ... a nasal aerosol,formulation, in 105 patients suffering ... double-blind, placebo-controlled study,included Rhinocort(R) as the steroid ...
... Helen eWard; Dynamic Site Drives Fight Against Childhood,Obesity by ... DETROIT, Oct. 29 Troy (Mich.) Chamber of ... Helen eWards,for Web Excellence, sponsored by Miller Canfield. The ... selected as the best site in the,Social Impact category ...
... genome has opened the door for proteomics by providing ... there is intense interest in applying proteomics to foster ... for diagnosis and early detection of cancer. Gastric carcinoma ... is the most common cause of cancer-related death in ...
... Abbott (NYSE: ABT ),will present at the 17th ... Thomas C. Freyman, executive vice president, finance,and chief financial ... 5,p.m. CST., A live audio webcast of the ... at http://www.abbottinvestor.com . An,archived edition of the presentation ...
... Berger & Montague,("Berger") announced today that a class action ... New York on behalf of all purchasers of,American Depository ... ("elan" or the "Company") and all purchasers of,options to ... 2008,through July 29, 2008 (the "Class Period") charging Elan ...
Cached Medicine News:Health News:Kaiser Family Foundation to Launch Non-Profit Health Policy News Service 2Health News:Kaiser Family Foundation to Launch Non-Profit Health Policy News Service 3Health News:Morria Biopharmaceuticals Plc Announces Preliminary Results Regarding Inflammatory Markers From its Phase II Study in Allergic Rhinitis 2Health News:Danialle Karmanos' Work It Out (DKWIO) Site Earns Recognition for Web Excellence 2Health News:Berger & Montague Announces Class Action Lawsuit Against Elan Corporation 2Health News:Berger & Montague Announces Class Action Lawsuit Against Elan Corporation 3Health News:Berger & Montague Announces Class Action Lawsuit Against Elan Corporation 4
(Date:7/31/2015)... 2015  Seeger Weiss LLP is reporting that on July ... letter to C.R. Bard, the manufacturer of Inferior vena ... correct violations the agency found at two of Bard,s facilities. ... FDA cited them during Inspectional Observations that occurred on November ... Tempe, AZ , location and on October 6, 2014, ...
(Date:7/31/2015)... RnRMarketResearch.com adds Syringes and ... that provides an overview of syringes and needles ... in-house databases, secondary and primary research. ... pipeline spread across 124 pages, talking about 13 ... 5 figures is now available at http://www.rnrmarketresearch.com/syringes-and-needles-pipeline-review-2015-market-report.html ...
(Date:7/31/2015)... According to a new market research report " Sterilization ... Filtration, E-beam, Gamma), Services (Onsite & Offsite), Consumables (Indicators, Detergents, ... 2020", published by MarketsandMarkets, The Sterilization Equipment Market is expected ... CAGR of 7.6%.from 2015 to 2020. Browse ... and 37 F igures spread ...
Breaking Medicine Technology:Seeger Weiss LLP Reports That The FDA Has Issued A Warning Letter To IVC Filter Manufacturer, C.R. Bard 2Seeger Weiss LLP Reports That The FDA Has Issued A Warning Letter To IVC Filter Manufacturer, C.R. Bard 3Syringes and Needles Market Products Pipeline Review 2015 Report 2Syringes and Needles Market Products Pipeline Review 2015 Report 3Syringes and Needles Market Products Pipeline Review 2015 Report 4Syringes and Needles Market Products Pipeline Review 2015 Report 5Sterilization Equipment Market is Expected to Reach USD 6.1 Billion by 2020 2Sterilization Equipment Market is Expected to Reach USD 6.1 Billion by 2020 3Sterilization Equipment Market is Expected to Reach USD 6.1 Billion by 2020 4
... NEW BRUNSWICK, N.J., Jan. 14, 2011 McNeil Consumer Healthcare ... JNJ ) company, in July 2010 submitted to the ... a commitment to restore its operations to the level of ... Johnson companies. As part of this commitment, McNeil undertook a ...
... 2011 New clinical research data suggests that [18F] ... by physicians and provide accurate identification of beta amyloid ... to Alzheimer,s Disease (AD).  Flutemetamol, a GE Healthcare Positron ... development, is being studied to identify the uptake of ...
Cached Medicine Technology:Johnson & Johnson Provides Update on McNeil Consumer Healthcare Remediation; Announces Completion of Internal Assessment Phase of Comprehensive Action Plan 2GE Healthcare Presents Flutemetamol Data for Detection of Amyloid Plaque Linked to Alzheimer's Disease 2GE Healthcare Presents Flutemetamol Data for Detection of Amyloid Plaque Linked to Alzheimer's Disease 3
... MCA Multiple Clip Applier is an sterile, ... ligating clips. The instrument is preloaded with ... advance after each clip application. The instrument ... fast, efficient means of ligation. The clips ...
... Clip Applier is a reusable instrument that ... clips are designed to offer a fast, ... where an absorbable ligating device is indicated. ... at the ligation site and facilitates access ...
The Auto Suture™ SIGNET™ staplers place one staple each time the instrument handles are squeezed. The staples first penetrate the skin and are then formed, thus holding the tissue togethe...
Auto Suture MULTIFIRE PREMIUM skin stapler Disposable Loading Unit is a single use premium multi fire DLU that is available in four sizes....
Medicine Products: